TOWARDS THE PHYSIOLOGICAL-FUNCTION OF URIC-ACID

被引:677
作者
BECKER, BF
机构
[1] Department of Physiology, University of Munich, 8000 Munich 2
关键词
ALLANTOIN; ANGIOTENSIN CONVERTING ENZYME; CORONARY ENDOTHELIUM; CYCLOOXYGENASE; FREE RADICAL; HYPOCHLORITE; NEUTROPHILS; OXALATE; OXIDANT; XANTHINE OXIDASE;
D O I
10.1016/0891-5849(93)90143-I
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Uric acid, or more correctly (at physiological pH values), its monoanion urate, is traditionally considered to be a metabolically inert end-product of purine metabolism in man, without any physiological value. However, this ubiquitous compound has proven to be a selective antioxidant, capable especially of reaction with hydroxyl radicals and hypochlorous acid, itself being converted to innocuous products (allantoin, allantoate, glyoxylate, urea, oxalate). There is now evidence for such processes not only in vitro and in isolated organs, but also in the human lung in vivo. Urate may also serve as an oxidisable cosubstrate for the enzyme cyclooxygenase. As shown for the coronary system, a major site of production of urate is the microvascular endothelium, and there is generally a net release of urate from the human myocardium in vivo. In isolated organ preparations, urate protects against reperfusion damage induced by activated granulocytes, cells known to produce a variety of radicals and oxidants. Intriguingly, urate prevents oxidative inactivation of endothelial enzymes (cyclooxygenase, angiotensin converting enzyme) and preserves the ability of the endothelium to mediate vascular dilatation in the face of oxidative stress, suggesting a particular relationship between the site of urate formation and the need for a biologically potent radical scavenger and antioxidant.
引用
收藏
页码:615 / 631
页数:17
相关论文
共 123 条
  • [81] THE CORONARY ENDOTHELIUM - A HIGHLY-ACTIVE METABOLIC BARRIER FOR ADENOSINE
    NEES, S
    HERZOG, V
    BECKER, BF
    BOCK, M
    ROSIERS, CD
    GERLACH, E
    [J]. BASIC RESEARCH IN CARDIOLOGY, 1985, 80 (05) : 515 - 529
  • [82] NEES S, 1984, ADENOSINE RECEPTORS, P419
  • [83] OXIDATION OF LIPIDS .12. INHIBITION OF OXIDATION OF SOYBEAN PHOSPHATIDYLCHOLINE AND METHYL LINOLEATE IN AQUEOUS DISPERSIONS BY URIC-ACID
    NIKI, E
    SAITO, M
    YOSHIKAWA, Y
    YAMAMOTO, Y
    KAMIYA, Y
    [J]. BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN, 1986, 59 (02) : 471 - 477
  • [84] OBST O, 1990, Pfluegers Archiv European Journal of Physiology, V415, pR61
  • [85] ISOLATION OF AN ACTIVATOR FOR PROSTAGLANDIN HYDROPEROXIDASE FROM BOVINE VESICULAR GLAND CYTOSOL AND ITS IDENTIFICATION AS URIC-ACID
    OGINO, N
    YAMAMOTO, S
    HAYAISHI, O
    TOKUYAMA, T
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1979, 87 (01) : 184 - 191
  • [86] ONDETTI MA, 1988, CIRCULATION, V77, P74
  • [87] ORIGIN OF MAN
    OROWAN, E
    [J]. NATURE, 1955, 175 (4459) : 683 - 684
  • [88] PARMLEY LF, 1992, CAN J CARDIOL, V8, P280
  • [89] URIC-ACID IS A MAJOR ANTIOXIDANT IN HUMAN NASAL AIRWAY SECRETIONS
    PEDEN, DB
    HOHMAN, R
    BROWN, ME
    MASON, RT
    BERKEBILE, C
    FALES, HM
    KALINER, MA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (19) : 7638 - 7642
  • [90] URIC-ACID - RISK FACTOR FOR CORONARY HEART-DISEASE
    PERSKY, VW
    DYER, AR
    IDRISSOVEN, E
    STAMLER, J
    SHEKELLE, RB
    SCHOENBERGER, JA
    BERKSON, DM
    LINDBERG, HA
    [J]. CIRCULATION, 1979, 59 (05) : 969 - 977